BCL2L13 and clear cell renal carcinoma: Compared to HEK (human embryonic kidney) 293 T cells, the expression of BCL2L13 is much lower in clear cell renal cell carcinoma cell line 786-0 (Fig. 7A), consistent with the silico-based analyses.